{"id":9205,"date":"2026-05-19T15:25:41","date_gmt":"2026-05-19T15:25:41","guid":{"rendered":"https:\/\/www.centogene.com\/?page_id=9205"},"modified":"2026-08-26T08:57:32","modified_gmt":"2026-08-26T08:57:32","slug":"investidores","status":"publish","type":"page","link":"https:\/\/www.centogene.com\/pt\/about-us\/investors\/","title":{"rendered":"Investidores"},"content":{"rendered":"<section class=\"bloque-banner-titulo-page  estilo-bgimage-dark\" id=\"\">\r\n    \r\n    <div class=\"image-wrapper\">\r\n\r\n      <!-- include mp4 video on a loop -->\r\n              <img decoding=\"async\" class=\"\" src=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/02\/centogene-get-in-touch-contact-us-header-01.jpg-1500x675.webp\" alt=\"centogene-get-in-touch-contact-us-header-01.jpg\" \/>\r\n          <\/div>\r\n    <div class=\"container content-wrapper\">\r\n      <div class=\"row justify-content-start align-items-center\">\r\n\r\n\r\n        <div class=\"col-12 col-lg-6 animation fadeTop align-self-center\">\r\n                  <h1>A Crown LiquidationCo NV apresenta as contas de liquida\u00e7\u00e3o e o plano de distribui\u00e7\u00e3o.<\/h1>\r\n                                      <\/div>\r\n\r\n      <\/div>\r\n    <\/div>\r\n\r\n<\/section>\r\n<div class=\"breadcrumbs\">\r\n    <div class=\"container\">\r\n      <div class=\"row\">\r\n        <div class=\"col-12\">\r\n          <ul id=\"breadcrumbs\" class=\"breadcrumbs\"><li><a href=\"https:\/\/www.centogene.com\/pt\/\">Home<\/a><\/li><\/ul>        <\/div>\r\n      <\/div>\r\n    <\/div>\r\n<\/div>\r\n\r\n\r\n\n\n\r\n    \r\n\r\n<section class=\"bloque-contenedor    transparente-my\"   id=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"\"> \r\n                                \r\n\r\n                <div class=\"acf-innerblocks-container\">\n\n<p class=\"wp-block-paragraph\"><strong>Crown LiquidationCo NV em liquida\u00e7\u00e3o<\/strong> (anteriormente Centogene NV) (o \u201c<strong>Empresa<\/strong>\u201d) anuncia que as Contas de Liquida\u00e7\u00e3o e o Plano de Distribui\u00e7\u00e3o (as \u201c<strong>Plano de Liquida\u00e7\u00e3o<\/strong>\u201dOs contratos foram finalizados e registrados na C\u00e2mara de Com\u00e9rcio Holandesa (Kamer van Koophandel) em 7 de agosto de 2026, e o registro foi anunciado de acordo com a legisla\u00e7\u00e3o holandesa em 8 de agosto de 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O liquidante dar\u00e1 continuidade \u00e0s atividades de liquida\u00e7\u00e3o restantes, conforme descrito no Plano de Liquida\u00e7\u00e3o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sujeito \u00e0 conclus\u00e3o das atividades de liquida\u00e7\u00e3o restantes, o Liquidante pretende proceder com uma distribui\u00e7\u00e3o final da liquida\u00e7\u00e3o dos recursos remanescentes da liquida\u00e7\u00e3o (se houver) (a \u201cSegunda Distribui\u00e7\u00e3o\u201d), conforme previsto no Plano de Liquida\u00e7\u00e3o.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A empresa fornecer\u00e1 uma atualiza\u00e7\u00e3o adicional no site de investidores a respeito da Segunda Distribui\u00e7\u00e3o (se houver), incluindo a data de registro e a data de pagamento aplic\u00e1veis, assim que forem definidas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-Liquidation-Accounts-Final.docx.pdf\" data-type=\"link\" data-id=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-Liquidation-Accounts-Final.docx.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Baixe o Plano de Liquida\u00e7\u00e3o<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong><strong>Avisos legais<\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Recomenda-se aos investidores que leiam atentamente e na \u00edntegra os materiais disponibilizados publicamente em rela\u00e7\u00e3o \u00e0 Assembleia Geral Extraordin\u00e1ria realizada em 4 de dezembro de 2024 e o formul\u00e1rio 6-K arquivado em 13 de novembro de 2024, pois cont\u00eam informa\u00e7\u00f5es importantes sobre a Companhia, sua liquida\u00e7\u00e3o e assuntos correlatos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este comunicado n\u00e3o constitui uma oferta, nem uma solicita\u00e7\u00e3o de oferta, para comprar ou subscrever quaisquer t\u00edtulos da Companhia. Este comunicado n\u00e3o se destina \u00e0 divulga\u00e7\u00e3o, publica\u00e7\u00e3o ou distribui\u00e7\u00e3o, total ou parcial, direta ou indireta, em qualquer jurisdi\u00e7\u00e3o em que tal divulga\u00e7\u00e3o, publica\u00e7\u00e3o ou distribui\u00e7\u00e3o seja ilegal.<\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong><strong><strong>Declara\u00e7\u00f5es prospectivas<\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Este comunicado cont\u00e9m &quot;declara\u00e7\u00f5es prospectivas&quot; conforme definido pelas leis federais de valores mobili\u00e1rios dos EUA. Declara\u00e7\u00f5es aqui contidas que n\u00e3o sejam claramente de natureza hist\u00f3rica s\u00e3o prospectivas, e palavras como &quot;antecipar&quot;, &quot;acreditar&quot;, &quot;continuar&quot;, &quot;esperar&quot;, &quot;estimar&quot;, &quot;pretender&quot;, &quot;projetar&quot;, &quot;planejar&quot;, &quot;est\u00e1 destinado a&quot;, &quot;potencial&quot;, &quot;prever&quot;, &quot;objetivo&quot; e express\u00f5es semelhantes, bem como verbos no futuro ou no condicional, como &quot;ir\u00e1&quot;, &quot;poderia&quot;, &quot;deveria&quot;, &quot;conseguiria&quot;, &quot;talvez&quot;, &quot;pode&quot; e &quot;pode&quot;, ou suas formas negativas, geralmente t\u00eam o objetivo de identificar declara\u00e7\u00f5es prospectivas. As declara\u00e7\u00f5es prospectivas podem incluir declara\u00e7\u00f5es sobre o montante de fundos (se houver) da Transa\u00e7\u00e3o dispon\u00edveis para pagamento aos acionistas da Companhia em uma distribui\u00e7\u00e3o de liquida\u00e7\u00e3o, os planos da Companhia para dissolver, liquidar e suspender suas obriga\u00e7\u00f5es de divulga\u00e7\u00e3o de informa\u00e7\u00f5es de acordo com as leis de valores mobili\u00e1rios dos EUA e quaisquer premissas subjacentes a qualquer das afirma\u00e7\u00f5es anteriores. Tais declara\u00e7\u00f5es prospectivas envolvem riscos conhecidos e desconhecidos, incertezas e outros fatores importantes que podem fazer com que os resultados, o desempenho ou as conquistas reais da Companhia sejam materialmente diferentes de quaisquer resultados, desempenho ou conquistas futuros expressos ou impl\u00edcitos nas declara\u00e7\u00f5es prospectivas. Tais riscos e incertezas incluem, entre outros, (i) o resultado de quaisquer processos judiciais relacionados \u00e0 Transa\u00e7\u00e3o, a dissolu\u00e7\u00e3o e liquida\u00e7\u00e3o da Companhia ou de suas subsidi\u00e1rias ou de outra forma, (ii) fatores econ\u00f4micos, comerciais e\/ou competitivos que possam afetar adversamente a Companhia, (iii) condi\u00e7\u00f5es econ\u00f4micas e geopol\u00edticas negativas e instabilidade e volatilidade nos mercados financeiros mundiais, (iv) poss\u00edveis mudan\u00e7as na legisla\u00e7\u00e3o, regulamenta\u00e7\u00e3o e pol\u00edticas governamentais atuais e propostas, (v) a capacidade da Companhia de otimizar o uso de caixa e (vi) a conformidade cont\u00ednua da Companhia com as cl\u00e1usulas contratuais vinculadas a instrumentos financeiros. Quaisquer declara\u00e7\u00f5es prospectivas contidas neste comunicado referem-se apenas \u00e0 data deste documento.<\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong>Mais informa\u00e7\u00f5es sobre a transa\u00e7\u00e3o e a liquida\u00e7\u00e3o.<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1757097\" target=\"_blank\" rel=\"noreferrer noopener\">Arquivo da Comiss\u00e3o de Valores Mobili\u00e1rios dos EUA<\/a><br><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/05\/Convening-notice-with-explanatory-notes-EGM-2024.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Aviso de convoca\u00e7\u00e3o com notas explicativas \u2013 AGE 2024.pdf<\/a> <br><a href=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-in-liquidatie-Announces-Cessation-of-Trading-on-OTC-Market-and-Advance-Liquidation-Distribution.pdf\" data-type=\"link\" data-id=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/08\/Crown-LiquidationCo-N.V.-in-liquidatie-Announces-Cessation-of-Trading-on-OTC-Market-and-Advance-Liquidation-Distribution.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Comunicado \u2013 A Crown LiquidationCo NV, em liquida\u00e7\u00e3o, anuncia a cessa\u00e7\u00e3o das negocia\u00e7\u00f5es no mercado OTC e a distribui\u00e7\u00e3o antecipada de ativos em liquida\u00e7\u00e3o.pdf<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading mt-5 has-medium-font-size\"><strong>Contato<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"mailto:Investor.relations@centogene.com\">Investor.relations@centogene.com<\/a><\/p>\n\n<\/div>\r\n          \r\n                            \r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":2015,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-9205","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investors | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pt\/sobre-nos\/investidores\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investors | CENTOGENE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pt\/sobre-nos\/investidores\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-26T08:57:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\",\"name\":\"Investors | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2026-05-19T15:25:41+00:00\",\"dateModified\":\"2026-08-26T08:57:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About us\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/about-us\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investidores | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pt\/sobre-nos\/investidores\/","og_locale":"pt_BR","og_type":"article","og_title":"Investors | CENTOGENE","og_url":"https:\/\/www.centogene.com\/pt\/sobre-nos\/investidores\/","og_site_name":"CENTOGENE","article_modified_time":"2026-08-26T08:57:32+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/about-us\/investors\/","url":"https:\/\/www.centogene.com\/about-us\/investors\/","name":"Investidores | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2026-05-19T15:25:41+00:00","dateModified":"2026-08-26T08:57:32+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/about-us\/investors\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/about-us\/investors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/about-us\/investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"About us","item":"https:\/\/www.centogene.com\/about-us\/"},{"@type":"ListItem","position":3,"name":"Investors"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Orientando a Medicina de Precis\u00e3o","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/pages\/9205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/comments?post=9205"}],"version-history":[{"count":24,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/pages\/9205\/revisions"}],"predecessor-version":[{"id":10788,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/pages\/9205\/revisions\/10788"}],"up":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/pages\/2015"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/media?parent=9205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}